Clinical Trial Update: Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of chloroquine or hydroxychloroquine in treating pneumonia caused by SARS-CoV-2/COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Chloroquine (chloroquine)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva | Conditions: COVID, COVID-19 | Phase 3 | Status: COMPLETED